PATENT CLAIM ANALYSIS

Application Number: 15768133
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "043000"]

Abstract:
The invention is directed to combinations of acamprosate and ribavirin, to pharmaceutical compositions, kits and treatment methods for the treatment or prevention of neurological damage.

Claim (Index 13):
The kit comprising the combination according to  claim 1 , wherein acamprosate or a pharmaceutically acceptable salt thereof and ribavirin or a pharmaceutically acceptable salt thereof are disposed in separate containers.

Metadata:
- Claim Count in Document: 22.0
- Percentile: 91.0
- Lexical Diversity: 1.21739
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14861169', '13691981', '13706907', '14473245', '14479614']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7244538775126211
- 35 USC 102 Novelty (BERT): 0.5215375333292137
- Combined Prediction Score: 0.7041622430942804
- Mean Citation Score: 278.174786
- Max Citation Score: 286.4421
- Similarity Product: 187.6356503342271

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test